Please assess the completion status of the following clinical trial:

Trial Title: Femoral Nerve Block With Bupivacaine and Adjuvant Dexamethasone in Patients With Hip Fracture

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical suspicion of hip fracture~* Age ≥ 55 years~* Mentally capable of comprehending and using verbal pain score~* Mentally capable of differentiating between pain from the fractured hip and pain from other locations~* Mentally capable of understanding the given information~* Arrival in the emergency room at times when one of the doctors who do the nerve blocks for this investigation are on call~* Verbal pain score (0-10) ≥ 7 with passive leg raise of the fractured leg at the time of inclusion~* Patients informed consent~Exclusion Criteria:~* Hip fracture not confirmed by x-ray~* Weight \< 40 kg~* Verbal pain score \> 3, 30 minutes after the nerve block~* Verbal pain score \> 5 with passive leg raise, 30 minutes after the nerve block~* Patient has previously been included in this trial~* Ongoing pre traumatic treatment with parenteral or intravenous adrenocortical hormone~* Verbal pain score \> 3 from other locations than the fractured hip~* If the patient wishes to be excluded~* Allergy to local anesthetics or adrenocortical hormone~* Visible infection in the area of the point of needle injection~* Acute inability to comprehend and use verbal pain score

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Saline (Type: PLACEBO_COMPARATOR): Bupivacaine with adrenaline with 2 ml. of Saline added
- Dexamethasone (Type: EXPERIMENTAL): Bupivacaine with adrenaline with 2 ml. of Dexamethasone added

Based on this trial design, predict the completion outcome and termination type (if applicable).